Amanote Research
Register
Sign In
To: A 24-Week, Randomized, Double-Blind Study of Donepezil in Moderate to Severe Alzheimer's Disease
Neurology
- United States
doi 10.1212/wnl.57.11.2153-a
Full Text
Open PDF
Abstract
Available in
full text
Categories
Neurology
Date
December 11, 2001
Authors
Unknown
Publisher
Ovid Technologies (Wolters Kluwer Health)
Related search
The Effect of Secukinumab on Moderate-To-Severe Scalp Psoriasis: Results of a 24-Week, Randomized, Double-Blind, Placebo-Controlled Phase 3b Study
Journal of the American Academy of Dermatology
Dermatology
Intramuscular Versus Oral Dexamethasone for the Treatment of Moderate-To-Severe Croup: A Randomized, Double-Blind Trial
Academic Emergency Medicine
Medicine
Emergency Medicine
Memantine Treatment in Patients With Mild to Moderate Alzheimer's Disease: Results of a Randomised, Double-Blind, Placebo-Controlled 6-Month Study
Journal of Alzheimer's Disease
Gerontology
Clinical Psychology
Mental Health
Psychiatry
Geriatrics
Medicine
Neuroscience
Donepezil Hydrochloride: A Double-Blind Study in Autistic Children
Journal of Pediatric Neurology
Child Health
Neurology
Pediatrics
Perinatology
A 24-Week, Randomized, Controlled Trial of Rivastigmine Patch 13.3 Mg/24 H Versus 4.6 Mg/24 H in Severe Alzheimer's Dementia
CNS Neuroscience and Therapeutics
Psychiatry
Mental Health
Physiology
Pharmacology
Comparison of Topical Tacrolimus 0.1 % in Pectin Ointment With Clobetasol 0.5% Ointment in Adults With Moderate to Severe Desquamative Gingivitis: A 4-Week, Randomized, Double-Blind Clinical Trial
Clinical Therapeutics
Pharmacology
Donepezil for Dementia in Parkinson's Disease: A Randomised, Double Blind, Placebo Controlled, Crossover Study
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
A Randomized Double-Blind Trial of Upward Progressive Versus Degressive Compressive Stockings in Patients With Moderate to Severe Chronic Venous Insufficiency
Journal of Vascular Surgery
Surgery
Cardiovascular Medicine
Cardiology
A Novel WNT Pathway Inhibitor, SM04690, for the Treatment of Moderate to Severe Osteoarthritis of the Knee: Results of a 24-Week, Randomized, Controlled, Phase 1 Study
Osteoarthritis and Cartilage
Sports Medicine
Rheumatology
Orthopedics
Biomedical Engineering
